Erika Edwards
Coverage of Erika Edwards in the Nexus archive.
- Breakthrough pancreatic cancer treatment could double survival time
A new study on the pancreatic cancer drug daraxonrasib shows it could double survival rates for over 90% of patients. Researchers are investigating its potential effectiveness in lung, ovarian, and colorectal cancers.
- New blood test is added an an option for colorectal cancer screenings
A new blood test for colorectal cancer has been added to the American Cancer Society's recommended screenings. It serves as an alternative to colonoscopies, aiming to increase screening rates among people who might not otherwise get tested.
- Experimental new drug could revolutionize pancreatic cancer treatment, doctors say
A new experimental drug could double the survival rates of thousands in the US with advanced stages of pancreatic cancer. Doctors consider this a breakthrough in pancreatic cancer treatment. The drug's advancements and side effects are being detailed by NBC News' Erika Edwards.
- FDA grants quick review for 3 psychedelic drug trials
The FDA has expedited the review of three experimental psychedelic drugs intended to treat major depression and post-traumatic stress disorder. NBC News' Erika Edwards highlights the FDA's evaluation process for safety and efficacy of these drugs.
- New study reveals no negative effects of fluoride on brain function
A long-term study tracking over 10,000 individuals for decades found no negative impact of fluoride on brain function. The research, highlighted by NBC News' Erika Edwards, suggests fluoride is safe for cognitive health.